Cargando…
Advances in the Management of Central Nervous System Metastases in Non-Small Cell Lung Cancer
SIMPLE SUMMARY: Central nervous system (CNS) metastases are common and challenging to manage among patients with non-small cell lung cancer (NSCLC). Here we provide an overview on lung cancer CNS metastases, including our evolving understanding of the genetic landscape, treatment updates, and future...
Autores principales: | D’Aiello, Angelica, Miao, Emily, Cheng, Haiying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913558/ https://www.ncbi.nlm.nih.gov/pubmed/36765802 http://dx.doi.org/10.3390/cancers15030844 |
Ejemplares similares
-
Temporal genomic heterogeneity guiding individualized therapy in recurrent non-small cell lung cancer
por: Fang, Qiyu, et al.
Publicado: (2023) -
Advances in the Management of Central Nervous System Metastases from Breast Cancer
por: Avila, Jorge, et al.
Publicado: (2022) -
Analysis of KRAS and BRAF genes mutation in the central nervous system metastases of non-small cell lung cancer
por: Nicoś, Marcin, et al.
Publicado: (2015) -
Pembrolizumab for non‐small cell lung cancer with central nervous system metastases: A two‐case report
por: Di, Mingyi, et al.
Publicado: (2019) -
Prevalence of NRAS, PTEN and AKT1 gene mutations in the central nervous system metastases of non-small cell lung cancer
por: Nicoś, Marcin, et al.
Publicado: (2017)